| CTRI Number |
CTRI/2025/09/094851 [Registered on: 16/09/2025] Trial Registered Prospectively |
| Last Modified On: |
15/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Preventive Dentistry |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Can Virtual Reality Make Quitting Smoking Easier? Testing a New Health Education Approach |
|
Scientific Title of Study
|
Efficacy Of Virtual Reality - Assisted Health Education In Smoking Cessation - A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sudhanish Neelakandan |
| Designation |
Principal Investigator |
| Affiliation |
Tamil Nadu Government Dental College and Hospital |
| Address |
Room no. G-3 ,
Department of Public Health Dentistry,
Tamil Nadu Government Dental College & Hospital No.1,TNPSC Road,
Park Town,
Chennai-600003 Chennai TAMIL NADU 600003 India |
| Phone |
9566665066 |
| Fax |
|
| Email |
sudhanishneela19@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr.S.G.Ramesh Kumar |
| Designation |
Assistant Professor |
| Affiliation |
Tamil Nadu Government Dental College and Hospital |
| Address |
Room no : G-3,
Department of Public Health Dentistry,
Tamil Nadu Government Dental College & Hospital No.1,TNPSC Road,
Park Town,
Chennai - 600003 Chennai TAMIL NADU 600003 India |
| Phone |
9840792950 |
| Fax |
|
| Email |
ramesh172000@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Sudhanish Neelakandan |
| Designation |
Postgraduate Student |
| Affiliation |
Tamil Nadu Government Dental College and Hospital |
| Address |
Room no. G-3,
Department of Public Health Dentistry,
Tamil Nadu Government Dental College & Hospital,Chennai No.1,TNPSC Road,
Park Town,
Chennai - 600003 Chennai TAMIL NADU 600003 India |
| Phone |
9566665066 |
| Fax |
|
| Email |
sudhanishneela19@gmail.com |
|
|
Source of Monetary or Material Support
|
| Theme Based Research Grants - 2025,
The Tamil Nadu Dr. M.G.R. Medical University,No.69,Annasalai,Little Mount,Guindy,Chennai,Tamil Nadu-600032,India. |
|
|
Primary Sponsor
|
| Name |
The Tamil Nadu Dr. M.G.R. Medical University |
| Address |
No.69,Anna Salai,
Guindy, Chennai – 600032. |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sudhanish Neelakandan |
Tamil Nadu Government Dental College & Hospital |
Room no : G-03,
Department of Public Health Dentistry
Chennai TAMIL NADU |
9566665066
sudhanishneela19@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| TAMILNADU GOVERNMENT DENTAL COLLEGE AND HOSPITAL INSTITUTIONAL ETHICAL COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Current smoking tobacco users aged 18 years to 64 years. |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Audio Visual assisted health education |
The control group participants will receive the routine audio-visual assisted health education for smoking cessation for a duration 15-30 mins |
| Intervention |
Virtual Reality Headset for Smoking Cessation |
The study group will receive VR-based tobacco cessation interventions along with routine health education for a duration of 15 - 30 mins |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
64.00 Year(s) |
| Gender |
Both |
| Details |
Current smoking tobacco users aged 18 years to 64 years. |
|
| ExclusionCriteria |
| Details |
1. Physically and mentally challenged individuals.
2. Subjects currently using NRT or anti-depressants.
3. Subjects diagnosed with oral cancer.
4. Subjects diagnosed with epileptic conditions.
5. Subjects diagnosed with cardiac conditions. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
To assess the level of tobacco dependence using the Fagerstrom addiction scale before and
after intervention. |
At the baseline and after 1 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To evaluate the self-reported tobacco abstinence between VR and
control group. |
At 1,3, & 6 months |
To evaluate the tobacco abstinence using Carbon monoxide breath
analyser between VR & control group. |
At 1,3 & 6 months |
|
|
Target Sample Size
|
Total Sample Size="350" Sample Size from India="350"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [sudhanishneela19@gmail.com].
- For how long will this data be available start date provided 02-01-1970 and end date provided 02-01-1970?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
A randomised controlled study is designed to assess the efficacy of virtual reality-assisted
health education in smoking cessation among smokers visiting tertiary care centres. The tobacco users
of age 18 years to 64 years attending Tobacco Cessation Clinic at Department of Public Health
Dentistry, Tamil Nadu Government Dental College and Hospital satisfying the eligibility criteria are
recruited for the present study. Physically and mentally challenged individuals, subjects currently
using NRT or anti-depressants, those diagnosed with oral cancer, subjects diagnosed with epileptic
conditions and those diagnosed with cardiac conditions are excluded from the study.
A simple random sampling technique is employed to select the desired sample of participants.
The study participants are clearly informed about the purpose of the study by providing patient
information sheet. Written informed consent is obtained from the study participants. Then, the
participants are randomly allocated into study and control groups using a computer-generated random
sequence.
The study group will receive VR-based tobacco cessation interventions along with routine
health education. The control group participants will receive the routine audio-visual assisted health
education for smoking cessation. Both the group participants will receive interventions for a duration
of 15 – 30 minutes in each session. A quit date would be fixed for both study and control group leaving
14 days from the first visit as grace time for reducing tobacco use. The participants are followed up
from the quit date for 1, 3 and 6 months to evaluate the fagerstorm addiction scores, self-reported
continuous tobacco abstinence and point prevalence tobacco abstinence and relapse rates.
|